From Deloitte Executive Chairman to Healthcare Director: Michael Fucci’s Next Chapter at Acadia Healthcare
Acadia Healthcare Company, Inc., a prominent provider in the behavioral healthcare sector, has recently announced the appointment of Michael J. Fucci as an independent director on its Board of Directors. This strategic addition, effective immediately, expands the board to nine members, with eight being independent directors, thus enhancing the governance structure vital for the company’s ongoing growth and operational excellence.
Mike Fucci brings a wealth of experience to Acadia Healthcare, having held several key leadership positions throughout his distinguished career. Before retiring in September 2020, he served as Chairman Emeritus of Deloitte U.S., a role in which he showcased his expertise in governance, organizational strategy, and risk management. His tenure also included a significant period as Executive Chairman from 2015 to 2019, during which he was instrumental in steering Deloitte through various challenges, including leadership succession planning and executive compensation evaluation.
Fucci’s extensive background at Deloitte U.S. complements Acadia Healthcare’s mission of delivering high-quality behavioral health services. During his time there, he was a member of both the U.S. and Global Boards of Directors, contributing to critical discussions around risk mitigation and corporate governance. His leadership extended beyond traditional corporate roles; he established and co-chaired the Board Leadership Forum, a coalition of prominent board chairs and lead directors aimed at addressing evolving business conditions.
In welcoming Fucci to the board, Reeve B. Waud, Chairman of Acadia’s Board of Directors, expressed confidence in the value that Fucci’s unique perspective will bring. “His impressive tenure of leadership experience as a principal and practitioner at Deloitte U.S. makes him an ideal Board member for Acadia,” Waud stated. The Chairman emphasized that Fucci’s insights into human resource transformation and corporate talent strategies would be pivotal as the company continues to execute its growth strategy and prioritize long-term value for shareholders.
Acadia Healthcare operates an extensive network of behavioral healthcare facilities, delivering essential services across various settings, including inpatient psychiatric hospitals and outpatient clinics. With over 18,200 beds in 589 facilities across 40 states, the United Kingdom, and Puerto Rico, Acadia is well-positioned to meet the increasing demand for mental health services—a need that has intensified in light of the COVID-19 pandemic.
In response to his new role, Fucci acknowledged the critical importance of Acadia’s mission. “I am honored to be joining the Acadia Board,” he stated, highlighting the company’s significant contribution to addressing the challenges posed by the ongoing mental health crisis. His commitment to supporting Acadia’s endeavors reflects a shared vision of enhancing behavioral healthcare accessibility and quality.
As Acadia Healthcare navigates the complexities of the behavioral health landscape, the inclusion of Mike Fucci on its board represents a strategic move toward fortifying its leadership team. His extensive experience and strategic acumen will undoubtedly aid in propelling the company forward as it strives to enhance patient care and operational efficiency in this vital sector. More information about Fucci can be found on his Crunchbase profile.
